Clinical Outcome Of Patients Experiencing Central Nervous System Progression On First-Line Pertuzumab And Trastuzumab For Her2-Positive Metastatic Breast Cancer In A Real-Life Cohort.
JOURNAL OF CLINICAL ONCOLOGY（2020）
摘要
2527Background: Isolated central nervous system (CNS) progression on first-line systemic therapy with Trastuzumab (T) and Pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) is a therap...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要